176.5 10ter Amarin Co. plc Analyst Ratings and Earnings History | $AMRN | NASDAQ:AMRN | Analyst Ratings Network

Analysts' Ratings and Earnings for Amarin Co. plc

Share on StockTwits

Lookup Another Company:  :  

Quick Links: Consensus Ratings, Ratings History, Earnings History, Company Description
Consensus Ratings for Amarin Co. plc (NASDAQ:AMRN) (?)
Ratings Breakdown: 1 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy
Consensus Price Target: $17.65 (167.42% upside)

Analysts' Ratings History for Amarin Co. plc (NASDAQ:AMRN)
DateFirmActionCompanyOld RatingNew RatingOld Price TargetNew Price TargetDetails
5/20/2013MKM PartnersReiterated RatingAmarin Co. plc (AMRN)Buy$12.00View
5/10/2013Lazard Capital MarketsBoost Price TargetAmarin Co. plc (AMRN)Buy$11.00$12.00View
5/10/2013MKM PartnersReiterated RatingAmarin Co. plc (AMRN)Buy$12.00View
5/9/2013Leerink SwannReiterated RatingAmarin Co. plc (AMRN)OutperformView
4/25/2013Lazard Capital MarketsLower Price TargetAmarin Co. plc (AMRN)Buy$13.00$11.00View
4/2/2013MKM PartnersReiterated RatingAmarin Co. plc (AMRN)Buy$12.00View
3/20/2013Chardan CapitalInitiated CoverageAmarin Co. plc (AMRN)Neutral$8.50View
3/6/2013Roth CapitalLower Price TargetAmarin Co. plc (AMRN)Buy$17.00$16.00View
3/1/2013AegisReiterated RatingAmarin Co. plc (AMRN)Buy$35.00View
1/8/2013Jefferies GroupLower Price TargetAmarin Co. plc (AMRN)Buy$26.00View
12/28/2012JPMorgan ChaseLower Price TargetAmarin Co. plc (AMRN)Overweight$20.00$18.00View
12/18/2012WedbushSet Price TargetAmarin Co. plc (AMRN)$15.00$10.00View
12/11/2012JPMorgan ChaseReiterated RatingAmarin Co. plc (AMRN)OverweightView
12/7/2012AegisBoost Price TargetAmarin Co. plc (AMRN)Buy$25.00$35.00View
12/7/2012Lazard Capital MarketsLower Price TargetAmarin Co. plc (AMRN)$16.00View
12/7/2012Canaccord GenuitySet Price TargetAmarin Co. plc (AMRN)Buy$26.00$19.00View
12/7/2012WedbushReiterated RatingAmarin Co. plc (AMRN)NeutralView
12/7/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)Buy$28.00View
12/6/2012CitigroupInitiated CoverageAmarin Co. plc (AMRN)Buy$20.00View
11/27/2012CitigroupInitiated CoverageAmarin Co. plc (AMRN)Buy$20.00View
11/26/2012WedbushReiterated RatingAmarin Co. plc (AMRN)NeutralView
11/21/2012Leerink SwannReiterated RatingAmarin Co. plc (AMRN)OutperformView
11/19/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)Buy$28.00View
11/9/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)Buy$28.00View
10/9/2012Roth CapitalReiterated RatingAmarin Co. plc (AMRN)BuyView
10/5/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)Buy$26.00View
10/3/2012WedbushDowngradeAmarin Co. plc (AMRN)OutperformNeutralView
9/12/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
9/11/2012Leerink SwannReiterated RatingAmarin Co. plc (AMRN)OutperformView
9/11/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyBuy$26.00View
9/5/2012MKM PartnersReiterated RatingAmarin Co. plc (AMRN)BuyView
9/4/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
8/21/2012JPMorgan ChaseReiterated RatingAmarin Co. plc (AMRN)OverweightView
8/20/2012MKM PartnersReiterated RatingAmarin Co. plc (AMRN)BuyView
8/20/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
8/9/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
8/9/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)Buy$27.00$26.00View
7/27/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
7/27/2012Leerink SwannReiterated RatingAmarin Co. plc (AMRN)OutperformView
7/26/2012Jefferies GroupBoost Price TargetAmarin Co. plc (AMRN)$26.00$28.00View
7/20/2012MKM PartnersReiterated RatingAmarin Co. plc (AMRN)BuyView
7/19/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
7/12/2012MKM PartnersReiterated RatingAmarin Co. plc (AMRN)BuyView
7/9/2012AegisInitiated CoverageAmarin Co. plc (AMRN)Buy$25.00View
6/27/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)Buy$24.00$26.00View
6/11/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
5/9/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
4/30/2012CitigroupInitiated CoverageAmarin Co. plc (AMRN)Buy$20.00View
4/20/2012JPMorgan ChaseInitiated CoverageAmarin Co. plc (AMRN)Overweight$22.00View
3/28/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyPositiveView
3/28/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
3/19/2012Jefferies GroupLower Price TargetAmarin Co. plc (AMRN)$24.00View
3/13/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
3/1/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
1/17/2012Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
1/5/2012Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
11/21/2011Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
11/16/2011Canaccord GenuityReiterated RatingAmarin Co. plc (AMRN)BuyView
7/12/2011MKM PartnersInitiated CoverageAmarin Co. plc (AMRN)Buy$23.00View
6/14/2011Morgan JosephInitiated CoverageAmarin Co. plc (AMRN)BuyView
5/27/2011Jefferies GroupReiterated RatingAmarin Co. plc (AMRN)BuyView
5/23/2011Canaccord GenuityBoost Price TargetAmarin Co. plc (AMRN)$35.00View
5/16/2011Jefferies GroupBoost Price TargetAmarin Co. plc (AMRN)Buy$21.00$25.00View
5/16/2011Jefferies GroupBoost Price TargetAmarin Co. plc (AMRN)$21.00$25.00View
4/25/2011WedbushBoost Price TargetAmarin Co. plc (AMRN)Outperform$12.00$18.00View
4/19/2011Hapoalim SecuritiesBoost Price TargetAmarin Co. plc (AMRN)$12.00$23.00View
4/18/2011Canaccord GenuityBoost Price TargetAmarin Co. plc (AMRN)Buy$11.00$18.00View
4/6/2011ZacksReiterated RatingAmarin Co. plc (AMRN)NeutralNeutralView
3/31/2011Hapoalim SecuritiesReiterated RatingAmarin Co. plc (AMRN)Buy$12.00View
2/2/2011Jefferies GroupInitiated CoverageAmarin Co. plc (AMRN)BuyView
12/29/2010ZacksReiterated RatingAmarin Co. plc (AMRN)NeutralNeutralView
12/29/2010WedbushBoost Price TargetAmarin Co. plc (AMRN)Outperform$7.00$10.00View
12/23/2010Lazard Capital MarketsInitiated CoverageAmarin Co. plc (AMRN)Buy$10.50View
12/22/2010Lazard Capital MarketsInitiated CoverageAmarin Co. plc (AMRN)Buy$10.50View
Click Here to view only the most recent ratings from each analyst for this stock.

Earnings History for Amarin Co. plc (NASDAQ:AMRN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference Call
5/9/2013Q1 2013($0.39)($0.41)$5.21 million$2.34 millionView ReleaseN/A
2/28/2013Q4 2012($0.28)($0.28)View ReleaseN/A
11/8/2012Q312($0.22)($0.26)View ReleaseN/A
About Amarin Co. plc
Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company's product candidate is AMR101, an ultra-pure omega-3 fatty acid. It is developing AMR101 for the treatment of patients with high triglyceride levels, or hypertriglyceridemia. In September 2011, it filed a New Drug Application (NDA), with the United States Food and Drug Administration (FDA). In December 2011, it commenced patient dosing in its cardiovascular outcomes study of AMR101, titled REDUCE-IT (Reduction of Cardiovascular Events with eicosapentanoic acid (EPA) - Intervention Trial).


© Analyst Ratings Network 2006-2012. All rights reserved.
Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.